Pathology (Anatomic & Clinical) — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: path, AP/CP, "the doctor's doctor," lab medicine. Base residency you enter straight from medical school (no separate intern year). Organ systems: all of them, because pathology is the specialty of diagnosis itself, from a skin biopsy to a bone marrow to a blood bank.

The 30-second version

Pathology is the diagnostic engine of medicine, the specialty organized around the answer rather than around a single organ, age, or bedside. A surgeon sends a tumor. An oncologist needs to know exactly which leukemia this is before choosing chemo. A transfusion has to be matched safely, a Pap smear or a biopsy has to be read. In each case a pathologist is the physician who makes the call. Most of their audience is other doctors rather than patients, which is why the field's own nickname is "the doctor's doctor."

The work is cognitive, visual, and lab-based: a day at the multi-headed microscope (increasingly a monitor), at the grossing bench, and on the phone with clinicians. It comes with excellent schedule control, minimal overnight call, and one of the lowest burnout profiles in medicine. You give up the bedside and direct patient continuity in exchange for intellectual depth, boundaries, and sustainability. That trade is the whole personality of the field.

Quick dashboard (details and sources below)
Training after med school 4 years (AP/CP combined; 3 for AP-only or CP-only)
Total from college start ~12 years (4 undergrad + 4 med school + 4 residency); fellowship near-universal, +1–2
Competitiveness Low-to-moderate — one of the more accessible fields, and notably IMG/DO-open ⟳
Typical full-time pay ~$370,000–$390,000 total comp (general AP/CP) ⟳
Pay range (structure) 25th pct ~$320k · median ~$390k · 75th pct ~$450k; partners/top subspecialists $500k–$550k+ ⟳
Lifestyle Daytime/weekday, little traditional call — among the most controllable in medicine
Burnout Among the lowest in medicine — 28.3% on AMA 2025 against a 41.9% all-physician average ⟳
% women 44% of practicing pathologists; 54.7% of residents ⟳
DO / IMG accessibility Among the most open fields — 18.3% DO, 34.7% IMG of the entering class (NRMP 2026) ⟳

What they actually do

Pathologists examine tissue, cells, blood, and body fluids to establish or confirm the diagnoses that drive nearly every downstream treatment decision.1 The field splits into two broad tracks and most US graduates train in both.

Anatomic pathology (AP) is the visual, morphology-driven side: surgical specimens (biopsies and resections), cytology (Pap smears, fine-needle aspirates), and autopsy. The core act is reading a slide and rendering a diagnosis, often one that determines whether a patient has cancer and what kind.

Clinical pathology (CP) is the laboratory side, directing hematology, chemistry, microbiology, molecular diagnostics, and the blood bank. Here the pathologist runs the hospital lab and is the person who decides, for example, who gets which blood products.1

One thing premeds almost never hear: this is overwhelmingly living-patient medicine. The TV version, with its autopsies and causes of death, is one small subspecialty. Most of pathology is diagnosis on people who are very much alive. The biopsy that stages someone's cancer. The marrow that names their leukemia. The Pap smear that catches a precancer early.12 Pathologists are MD/DO physicians who complete a full residency and board certification, and seeing few patients in clinic is a different thing from not practicing medicine. The patient is on the slide.2

Representative tasks & procedures: sign-out at the multi-headed microscope (or whole-slide monitor) · grossing (dissecting and sampling surgical specimens at the bench) · frozen-section diagnosis for the OR while the surgeon waits · fine-needle aspiration and cytology interpretation · bone marrow interpretation · immunohistochemistry and special-stain interpretation · molecular/genomic test interpretation · directing the blood bank and transfusion service (including apheresis) · autopsy (a small share of most practices) · tumor-board presentation and clinician consultation.1

A day in the life. Mornings often start at the grossing bench or previewing the day's slides. The case load is what came in, so the work is largely task-bounded rather than driven by unpredictable acuity.1 You sit at the scope and sign out cases, interrupted by frozen sections from the OR, where a surgeon needs a diagnosis in minutes, and by clinician phone calls about results. You may staff a tumor board, review molecular results, and handle blood-bank questions. When the cases are signed out you are largely done. There is no clinic panel to carry, no floor of admitted patients, and little of the get-out-of-bed overnight call that defines surgery, OB, or EM.1

The training path & time to completion

Medical school (4 yrs) → Pathology residency (3–4 yrs) → (near-universal) fellowship (1–2 yrs) → board-eligible with ABPath. Pathology is entered directly from medical school as a categorical program, with no separate preliminary or transitional intern year.3

  • Three residency tracks. AP/CP combined (4 years) is the dominant choice for the large majority of residents. AP-only (3 years) and CP-only (3 years) are the single-track options.3
  • Fellowship is near-universal. Unlike EM, most pathology graduates complete at least one fellowship and often two (typically 1 year each) before practice, especially for competitive subspecialties or desirable-metro jobs.3 This is a real cost to weigh: it is more low-paid training years before a full attending income.
  • Board. The American Board of Pathology (ABPath) grants primary certification in AP/CP, AP-only, or CP-only, plus a broad set of subspecialty certificates (surgical pathology, cytopathology, hematopathology, dermatopathology, forensic, molecular genetic pathology, blood banking/transfusion, neuropathology, pediatric, and CP subspecialties).34
  • Total from the start of college. About 12 years (4 + 4 + 4) for AP/CP, plus 1–2 more for the typical fellowship or fellowships. There were 142 ACGME-accredited AP/CP programs in AY 2024–2025.5

How competitive is it?

Pathology is one of the less competitive specialties by the profile of who matches, and one of the most IMG- and DO-accessible fields in all of medicine. That accessibility is a genuine feature of the field rather than a comment on the work; see the FLI angle.

The counterintuitive part is that pathology fills nearly 100% of its seats, so "less competitive" does not mean empty programs. In the 2026 Main Match pathology offered 636 PGY-1 positions and filled 634 of them (99.7%), leaving 2 unfilled.6 It fills because applicant demand exceeds positions: 1,049 applicants ranked pathology, an applicant-to-position ratio of roughly 1.65:1.6 ⟳ "Less competitive" refers to the characteristics of matched applicants and the openness to DO and IMG graduates rather than to unfilled seats.

What that means for you today:

  • The entering class is unusually open. Of the 634 filled positions in 2026: US MD seniors 41.6%, US DO seniors 18.3%, and IMGs 34.7% (US-citizen IMGs 7.9% plus non-US IMGs 26.8%).6 That IMG share is among the highest of any specialty, and US MD seniors fill under half the seats. Both figures moved about a point and a half from 2025 and in opposite directions, the DO share up and the IMG share down.6 ⟳
  • Matched US-MD seniors had a mean USMLE Step 2 CK of 247 in 2024, against 250 across all specialties combined, consistent with lower competitiveness.7 ⟳
  • IMG match rates into pathology are relatively favorable. US IMGs about 44.1% and non-US IMGs about 43.8% in the 2024 cohort.8 ⟳

The honest read is that pathology is genuinely reachable from a wide range of schools and application profiles. The competitive pressure sits downstream of the residency door, in landing the job and location you want after training; see Compensation and the job-market debate.

Compensation — the robust version

Pathology pay is best understood as mid-tier for a physician with an unusually good pay-for-lifestyle ratio. Few high-controllability fields pay this well. A note on sources first: the surveys disagree because they measure different things. Treat Doximity, Medscape, and SalaryDr (a self-selected panel of 53) as anchors for total-comp magnitude and structure, and treat BLS as a base-wage floor concept that runs much lower because it excludes partnership distributions and bonuses.9101112

National number. Depending on source and definition, a general AP/CP pathologist lands anywhere from about $263,600 (BLS OEWS mean base wage, 2024) to about $373,000 (Doximity 2025), about $388,000 (Medscape 2025), and about $390,000 (SalaryDr panel, n=53). A defensible "typical full-time" figure for 2025–26 is $370,000–$390,000 total compensation.9101112 ⟳ Pathology has historically ranked in the middle of specialties, 16th of about 30 in older Medscape data, with figures drifting up from roughly $308k in 2019 to $339k in 2023 to the high $300Ks now.9 ⟳

The spread. SalaryDr 2026 puts the interquartile range at 25th percentile about $320,000, median about $390,000, and 75th percentile about $450,000.11 A clean single-survey 10th and 90th for general pathology was not found, since MGMA percentile tables are paywalled, but range-based secondary sources put 90th-percentile employed generalists in the $450k–$500k band and top-of-market partners higher.1113 ⟳

Seniority matters, but partnership matters more. Compensation climbs with experience: early-career (0–5 yr) about $315k, mid-career (6–15 yr) about $395k, senior (16+ yr) about $480k, per SalaryDr.11 The single largest lever in private practice is the jump from a salaried pre-partner (about $230k–$300k) to full partner with profit-sharing ($350k–$550k+), where you share the group's technical and professional revenue; those two bands, and the setting and subspecialty bands below, come from ResidencyAdvisor's pathology salary guide rather than from a benchmark survey.13 ⟳ A widely discussed "wage inversion" complicates the early years. Entry salaries have crept up while locum and per-diem rates have been roughly flat for about 15 years, and repeated Medicare and commercial-payer cuts to anatomic-pathology fees have compressed per-case revenue and pre-partner pay, so some early-career and locums pay looks squeezed relative to trainee expectations.14 ⟳ (That wage-inversion narrative comes largely from physician-forum discussion. It is anecdotal rather than survey data.)

Setting is a major driver, running partnership, then commercial lab and hospital-employed, then academic.1315

  • Academic. Lowest cash compensation. You trade pay for protected research and teaching time and subspecialty focus. Subspecialty academic starts commonly $230k–$380k.1315 ⟳
  • Non-academic hospital or medical center. Higher than academic, salaried W-2 with productivity incentives. CAP found non-academic hospitals and independent labs made "substantially more" than academics.15 ⟳
  • Private practice (partnership). The highest ceiling via profit-sharing, $350k–$550k+ at partner level.13
  • Commercial or reference lab (Quest, LabCorp-type). Corporate W-2, stable and competitive but with no ownership upside. Molecular and industry roles there can reach $350k–$500k+.13 ⟳

Geography, where high-supply coastal metros pay less.1617

  • BLS base wage (2024). Highest are lower-cost Midwest and Mountain states: Nebraska $323,510, Indiana $312,000, New Hampshire $311,210, Michigan $303,370. Lowest are expensive coastal markets: California $216,910, Maryland $220,030, New York $224,790, DC $237,290.16 ⟳
  • This page used to set a second, opposing state ranking beside it, from ZipRecruiter job postings. Postings are cost-of-living loaded and have no panel behind them, so the disagreement was between a wage survey and an artifact.17
  • The pattern. High-cost, high-supply coastal metros (SF, LA, NYC, Boston, DC, Baltimore) tend to pay pathologists less in real terms because supply is high. The Midwest, Mountain West, South, and rural and underserved areas pay more to attract candidates.1617 ⟳ (No pathology-specific metro or urban/rural dollar table is published; the pattern is inferred from the two state datasets.)

The high-earning subspecialties, and the notable low one. The premium subspecialties are dermatopathology, hematopathology, molecular and genomic pathology, and cytopathology. Forensic pathology is conspicuously low despite acute demand.1819 The per-subspecialty dollar bands are ResidencyAdvisor's, since no compensation survey breaks pathology out this finely.13

  • Dermatopathology. No compensation survey publishes a dermatopathology line. The figures that circulate come from job-board aggregators and land around $270k ($250k–$280k typical), which sits below the general AP/CP range above it — so treat the aggregator number as a floor on employed roles rather than as the subspecialty's pay. Private high-volume and partner roles are reported at $380k–$550k+, from the same kind of source.1813 ⟳
  • Hematopathology. Non-academic post-partnership $370k–$520k+.13 ⟳
  • Molecular and genomic pathology. Academic and research $230k–$350k, but industry and reference labs $350k–$500k+.13 ⟳
  • Cytopathology. Private and hospital $330k–$460k.13 ⟳
  • Blood banking and transfusion, neuropathology, pediatric pathology. Mostly $280k–$400k, academic lower.1319 ⟳
  • Forensic pathology. Typically $200k–$300k, and medicolegal (government ME or coroner) offices pay less than hospital-based pathology. That holds even though roughly 500,000 deaths a year are referred to coroners and MEs, and NAME estimates nearly twice as many forensic pathologists are needed. The gap between hospital and medicolegal pay is explicitly cited as a driver of the national forensic shortage.19 ⟳

How you are actually paid. Employment models range from partnership (salaried buy-in about $230k–$300k, then profit-sharing) to hospital-employed (W-2, RVU or flat plus bonus, mid-$300Ks) to commercial and reference-lab (corporate W-2, capped) to locum and per-diem. The locum market runs about $98–$145 an hour and per-diem about $800–$1,000 a day, with agencies marking practices up to roughly $1,250–$1,300 a day and forensic per-diem up to about $1,500 a day cited anecdotally. Full-time locum annualizes to about $269k.1320 ⟳ Locum rates being flat for about 15 years is a recurring sore point.14 ⟳

The trend that colors all of it: lab consolidation and the job-market debate. Continued absorption of hospital and independent labs by national reference labs (Quest, LabCorp) and hospital-system integration is reducing the number of independent partnership tracks and shifting pathologists toward salaried corporate models with capped upside.21 Layered on top of that: modest overall pay growth of about 3.7% in 2024, ongoing reimbursement pressure, the rise of digital pathology and AI-assisted whole-slide imaging, and strong demand in molecular and genomic testing that keeps those subspecialties among the best-paid. The near-term effect of the imaging shift is on workflow and remote sign-out more than on headline pay, and its long-term impact is genuinely contested.2110 ⟳

Lifestyle & the controllable-schedule bargain

The single most-cited pro of pathology is schedule control with minimal acute call. It is a predominantly daytime, weekday specialty. There is call: frozen sections during OR hours, transfusion and blood-bank coverage, occasional autopsy or forensic call. But there is very little of the traditional overnight, get-out-of-bed, life-or-death call that defines surgery, OB, or EM, and almost none of the clinic-style throughput pressure of primary care.1 Typical hours run roughly 45–55 a week, with many community jobs comfortably in the 40s and academic or high-volume sign-out practices running longer.1

The work is largely task-bounded, in the sense that the case load is what it is, so it is genuinely easier to finish and go home than in fields with unpredictable acuity. Part-time and phased-retirement arrangements are relatively feasible.1 The work is desk, microscope, and lab-based, and increasingly location-flexible as whole-slide imaging enables some remote sign-out.1

The flip side of the same coin is minimal direct patient contact. Most pathologists rarely or never see living patients face to face, the exceptions being cytopathology FNA clinics, transfusion medicine, and apheresis.1 For many that is the appeal and for others it is the dealbreaker. Know which you are before you commit.

Lifestyle rating: 4/5. High schedule control and predictability with little acute call, tempered mainly by frozen-section and OR coverage and by high-volume sign-out demands.

Wellbeing — the quietly good story

Burnout: pathology is among the lowest of all specialties, on both instruments that publish a row for it. The AMA's 2025 Organizational Biopsy, which is free to read and covers about 19,000 physicians across 38 states, puts pathology at 28.3% against a 41.9% all-physician average — third-lowest of the fields it names, behind infectious diseases and ophthalmology.1 Medscape's 2024 reporting is the second instrument and agrees on the direction, placing pathology near the bottom of the pack at about 41% against emergency medicine at the top at about 63%, and well below the perennial high-burnout leaders in EM, IM, OB/GYN, and family medicine.22 ⟳ The levels are not comparable, because Medscape's all-physician baseline is 49% and AMA's is 41.9%, so a rank has to name its survey. Both surveys reach the same conclusion: the cognitively demanding but physically light, low-acute-stress nature of the work protects wellbeing.

Happiness and satisfaction. Pathology scores comparatively well on quality-of-life measures: around 62% "happy outside of work" on Medscape's 2024 lifestyle measure, and on a different Medscape 2025 question about whether work-life balance is possible, pathology ranked near the very top at about 88%, second only to allergy and immunology.23 ⟳ (Those are different questions in different years. Do not merge them.) Pathologists who self-select into the field tend to genuinely enjoy the intellectual content and regret rates are modest. The people who leave usually discover they missed patient relationships rather than that the work itself disappointed.1

Career longevity is excellent, and this is a real differentiator. Because the work is cognitively demanding but physically light and low in acute stress, pathology is one of the most sustainable late-career fields in medicine. Pathologists routinely practice productively into their 60s and 70s and part-time wind-down is common, a sharp contrast to shift-based or physically grinding specialties where attrition comes early.1

Who's in the field (demographics)

  • Women. 44% of practicing anatomic and clinical pathologists on AAMC's 2022 data, five points above the ~38.7% all-physician average. Residents are 54.7% women in AY2024-25, so the trainee cohort has passed parity and the workforce is following it up.2425 ⟳
  • DO. 18.3% of the entering class in the 2026 Match, up from 16.8% in 2025, so pathology is comparatively DO-open and getting more so.6 ⟳
  • IMG. 34.7% of the entering class in the 2026 Match, down from 36.3% in 2025, still among the highest IMG shares of any specialty and a genuine, well-established entry point for international graduates.6 ⟳
  • URiM. 17.2% of pathology residents, 413 of 2,400 in AY2024-25, are Hispanic/Latino or Black/African American. That is exactly the figure for all US residents on the same table, 28,758 of 167,083, so pathology sits at the all-resident average rather than below it.26 ⟳ Two honest caveats: URiM definitions differ in whether they fold in multiple-race and Native Hawaiian or Pacific Islander categories, and 89 pathology residents are recorded as unknown, so the denominator is soft at the margins. The like-for-like comparison holds because both figures come from the same table.

Culture, personality & the online stereotypes

Who gravitates here. Intellectually driven diagnosticians who love the why behind disease, meaning mechanism, morphology, and the final answer rather than only the workup. Detail- and pattern-recognition minds and visual thinkers who enjoy microscopy and building a differential from a slide. People comfortable being the consultant other doctors depend on rather than the face at the bedside. Those who want intellectual depth without the physical grind and unpredictable hours of procedural specialties.1 Many are drawn precisely to the boundaries, and to the ability to finish the work and go home. As always, plenty of people in the field do not fit any single mold.

The stereotypes, which are community caricatures rather than facts, each with an unfair edge:

  • "Pathologists aren't real doctors / they never see patients." False. They are MD/DO physicians who complete residency and board certification and make the diagnoses that drive treatment. Seeing few patients is a different thing from not practicing medicine. The patient is on the slide.2
  • "They only do autopsies / work with dead people." A misconception. Autopsy and forensics is a small slice. The overwhelming majority of pathology is diagnosis on living patients: biopsies, Pap smears, blood work, the cancer staging that determines someone's chemo.2
  • "They hide in the basement." Labs are often physically tucked away, but the work is deeply integrated. Tumor boards, clinician consults, and lab leadership put pathologists at the center of care decisions.2
  • "It's an IMG/DO 'backup' specialty." Unfair. Pathology is more IMG- and DO-accessible than many fields, which is a real and positive access feature covered in the FLI section, but that reflects openness and match dynamics rather than lower rigor or prestige.1

What people say online, synthesized and paraphrased rather than quoted. Across trainee and physician forums the field is repeatedly described as a "secret" or "underrated" lifestyle specialty, with great hours, intellectual richness, and pay that surprises people relative to the workload. There is a strong self-selection culture: people either love the microscope and diagnostic reasoning or quickly realize it is not their "why," and because medical-school exposure is thin, many discover the field late or not at all.

The job-market debate is the recurring live wire and the honest synthesis is two-sided. For years the dominant worry was oversupply: too many residency and fellowship spots relative to good geographic openings, with new graduates sometimes stacking multiple fellowships and facing tight markets in desirable cities. More recent discussion, and CAP and ASCP workforce research, has swung toward concern about an aging workforce and a looming shortage, with one study arguing the pathologist workforce had been undercounted by nearly 40% in some national reports. The nuanced reality is that national demand looks healthier than the old doom narrative while geography still governs your options. Desirable metros stay competitive and rural and underserved areas have more openings. Treat "the job market" as location- and subspecialty-dependent rather than as a single verdict.27

Voices from the field. Paraphrased from public writing, with links to the originals:

  • The College of American Pathologists frames the field's appeal as intellectual variety, central diagnostic impact, the AP/CP mix, strong lifestyle and schedule control, and being at the frontier of molecular and digital medicine.28
  • A pathologist writing for KevinMD in January 2025 pushes back on the "not a real doctor / just autopsies / hidden in the basement" myths, emphasizing that pathologists are physicians whose diagnoses drive the majority of clinical and lab-based care decisions.2
  • An AMA specialty profile has pathologists describe the intellectual breadth, the consultative "physician's physician" role, and the controllable lifestyle, while naming limited patient contact as a genuine trade-off to weigh.29
  • A trainee reflection in Doximity's Op-Med walks through entering pathology, the residency match, and what draws people to the field's diagnostic focus and lifestyle.30

Why people choose it / why people leave

Why choose it. You are the diagnosis, across an enormous range of disease and organ systems · excellent, controllable daytime and weekday lifestyle with little traditional call · pay that is genuinely good for the hours · a central, respected role as the consultant every clinical service relies on · sustainable across a full career with easy part-time wind-down · at the frontier of molecular and digital medicine · one of the more accessible high-lifestyle fields for IMGs and DOs.128

Why leave or avoid it. If your "why" for medicine is patient relationships and bedside care, the limited contact will feel like a loss · a historically variable, geography-dependent job market and heavy fellowship expectations for competitive locations and subspecialties · low medical-school visibility means thin mentorship and a career you have to seek out · lab consolidation into corporate models is compressing partnership tracks · a less procedural, less hands-on-patient identity that leaves some feeling disconnected from clinical medicine.1

Best fit if. You love diagnostic reasoning and visual pattern recognition · you want intellectual depth without unpredictable hours · you're comfortable being the "doctor's doctor" behind the scenes · you value long-term schedule control and career sustainability · you're energized by the microscope and the lab, not the clinic.1

Not for you if. You need direct patient contact and continuity to feel fulfilled · you want a highly procedural or acute-care identity · you require guaranteed placement in one specific competitive city right after training · low medical-school exposure would leave you without the mentorship you need to commit.1

The FLI angle — Pathology for first-gen, low-income & immigrant students

Pathology is one of the strongest risk-adjusted picks in medicine for FLI students, a genuinely attainable good-lifestyle path that pairs real accessibility with real quality of life.

Where pathology fits FLI realities well:

  • Genuine access, which is the headline. Pathology is among the most IMG- and DO-friendly competitive-lifestyle fields in all of medicine: about 35% of the entering class are IMGs and about 18% are DOs in the 2026 Match, with relatively favorable IMG match rates.68 For a first-gen, immigrant, or DO applicant, this is one of the few fields that combines an excellent lifestyle and more forgiving match odds. It is realistically reachable from a wider range of schools and application profiles than the ROAD or surgical-subspecialty fields.
  • Lifestyle and pay, which is a rare combination. Excellent schedule control with solid mid-pack compensation of about $370k–$390k means you can build financial stability and repay loans without sacrificing your whole life to call and shift work. Few high-controllability fields pay this well.111
  • Sustainability protects the breadwinner. The low physical and acute-stress grind protects wellbeing and longevity, which is valuable if you are supporting family and simply cannot afford a burnout-driven career interruption. Pathologists practice productively for decades, which lengthens the earning horizon.1

Risks to name honestly:

  • The job market is geography-dependent, and fellowship is near-universal. Historically it has been tighter and more location-dependent than many fields. You may need flexibility on where you practice, and competitive metros and subspecialties can require extra fellowship years, which is more low-paid training before full income and matters if you need to start earning fast.327
  • Little patient contact. If your motivation for medicine is direct patient care or being a visible community doctor, pathology may not deliver on that "why," and that matters more than any statistic.1
  • Wage inversion and consolidation mean early-career and locum pay can look compressed, and the independent-partnership path, which is the biggest income lever, is narrowing under corporate lab consolidation.1421

Bottom line. Pathology is one of the few paths in medicine that is simultaneously accessible to FLI and DO/IMG applicants, high in lifestyle and career sustainability, and solidly if not spectacularly paid. The real trade-offs are the missing bedside, a geography-dependent job market, and the near-universal fellowship years. If the microscope and the diagnosis excite you more than the clinic, this is one of the most FLI-sensible good-lifestyle bets in medicine. Shadow a real sign-out session and a grossing bench before you commit.

Subspecialties & fellowships

Fellowship is near-universal in pathology (often two), and most take ~1 year each.34

  • Surgical pathology. The AP core: diagnosing disease from biopsies and resection specimens across all organ systems. A very common, often non-ACGME fellowship.
  • Cytopathology. Diagnosis from individual cells (Pap smears, FNAs), and one of the few subspecialties with some direct patient contact.
  • Hematopathology. Blood, bone marrow, and lymph node disorders including leukemias and lymphomas. Heavily molecular and among the best-paid.
  • Molecular genetic pathology. DNA and RNA-based diagnostics, tumor genomics, and precision-medicine testing. Fast-growing and high-demand.
  • Dermatopathology. Skin-biopsy diagnosis. Competitive, well compensated, and entered from pathology or dermatology.
  • Blood banking and transfusion medicine. Blood products, apheresis, and transfusion safety. More patient- and clinician-facing.
  • Forensic pathology. Autopsy-based cause and manner of death for ME and coroner systems. The smallest track, lower paid, with a documented workforce shortage.
  • Neuropathology. Diseases of brain, nerve, and muscle including brain tumors. Typically a longer fellowship.
  • Pediatric pathology. Pediatric and perinatal or placental disease diagnosis.
  • Cytogenetics and genomics. Chromosomal and genomic abnormality analysis, often paired with molecular training.
  • Clinical chemistry and clinical microbiology. CP subspecialties directing diagnostic lab sections.
  • Organ-system surgical-path niches (GI, GU, breast, gynecologic, pulmonary, bone and soft tissue), often built via fellowship plus practice focus.

Fun facts

  • Pathologists' diagnoses influence the large majority of medical decisions despite pathology being a small fraction of the physician workforce. Enormous leverage per doctor.1
  • "The doctor's doctor" is the field's own nickname. The consult audience is other physicians rather than patients.1
  • The TV version is the exception. Forensic pathology, with its autopsies and causes of death, is only a small subspecialty. Most pathology diagnoses are on living patients.1
  • Pathology sits on the front line of medical AI. Whole-slide imaging plus FDA-cleared AI diagnostic aids are moving into routine sign-out and remote work.21
  • It is one of the few specialties that toggles between two worlds: the microscope on the anatomic side, and running an entire hospital laboratory and blood bank on the clinical side.1
  • Transfusion medicine pathologists literally decide who gets which blood products, a high-stakes, behind-the-scenes patient-safety role most people never see.1

Sources

Footnotes

  1. Pathology lifestyle, culture, wellbeing, career longevity, who-gravitates, and role ("the doctor's doctor"; living-patient diagnosis; AP vs CP). Synthesis of Medscape Physician Lifestyle/Burnout reports (2024–2025), CAP, and community sentiment. Medscape Lifestyle (https://www.medscape.com/sites/public/lifestyle/2024) and Mental Health/Wellbeing (https://www.medscape.com/sites/public/mental-health/2025); CAP, "Top 5 Reasons To Be A Pathologist" (https://www.cap.org/member-resources/articles/top-5-reasons-to-be-a-pathologist). A second, freely readable instrument: the AMA's 2025 Organizational Biopsy (~19,000 physicians, 38 states) puts Pathology at 28.3% against a 41.9% all-physician average, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. It is primary where Medscape reaches this page through relays, and its baseline sits seven points below Medscape's 49% — the two never belong in the same sentence, and a cross-specialty rank must name which survey it comes from. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18 ↩19 ↩20 ↩21 ↩22 ↩23 ↩24 ↩25 ↩26 ↩27 ↩28

  2. Correcting the "not real doctors / just autopsies / basement" misconceptions. Christopher Naugler / pathologist author, KevinMD, "Dispelling misconceptions and myths about pathology and laboratory medicine" (Jan 2025). https://kevinmd.com/2025/01/dispelling-misconceptions-and-myths-about-pathology-and-laboratory-medicine.html ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  3. Training tracks (AP/CP 4 yr; AP-only / CP-only 3 yr; no separate intern year), near-universal fellowship, and board. American Board of Pathology, "Primary Certification" (https://abpath.org/certification-mark/, accessed 2026); ACGME Program Requirements — Pathology (https://www.acgme.org/specialties/pathology/overview/, 2023). ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  4. ABPath subspecialty certificates (surgical path, cytopath, hemepath, dermpath, forensic, molecular genetic, blood banking/transfusion, neuropath, pediatric, CP subspecialties). ABPath, "Subspecialty Certificates" (https://abpath.org/certification-mark/, accessed 2026). ↩ ↩2

  5. 142 accredited AP/CP pathology programs (AY 2024–2025). ACGME Data Resource Book AY 2024–2025, Table A.3. https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf ↩

  6. NRMP, Results and Data: 2026 Main Residency Match (May 2026) — pathology PGY-1: 636 offered, 634 filled (99.7%), 2 unfilled, 1,049 applicants (~1.65:1). Table 2 gives the filled positions as 264 US MD seniors, 26 US MD graduates, 116 US DO seniors, 8 US DO graduates, 50 US IMGs and 170 non-US IMGs, so on the positions-filled denominator this page uses throughout: US MD seniors 41.6%, US DO seniors 18.3%, US IMG 7.9%, non-US IMG 26.8%, total IMG 34.7%. https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf Corrected 2026-08-17: every 2025 figure this page carried was exact against NRMP 2025 — 622 offered, 619 filled, 99.5%, 1,018 applicants, US MD 42.5%, DO 16.8%, US IMG 9.2%, non-US IMG 27.1% — but the 2026 edition published in May 2026 and this profile was reviewed in July. Two of the figures move about a point and a half in opposite directions, so the update is not cosmetic: the DO share rises to 18.3%, which strengthens the accessibility argument, and the IMG share falls to 34.7%, which softens it. The dashboard row also carried no year and now does. 2025 report: https://www.nrmp.org/wp-content/uploads/2025/05/Main_Match_Results_and_Data_20250529_FINAL.pdf ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  7. NRMP, Charting Outcomes in the Match: U.S. MD Seniors, 2024 (Aug 2024), Table PTH-1 — matched pathology US-MD seniors (n=213): mean Step 2 CK 247 (unmatched 232), mean Step 1 235, 12.4 contiguous ranks, 3.1 research experiences, 8.4 abstracts and publications. All specialties combined: 250 matched. https://www.nrmp.org/wp-content/uploads/2024/08/Charting_Outcomes_MD_Seniors_2024-2.pdf. Corrected 2026-08-13: this page carried 253, which is not pathology's figure in that report. ↩

  8. NRMP, Charting Outcomes: International Medical Graduates, 2024 (Aug 2024) — pathology IMG match rates: US IMGs 60/136 (44.1%), non-US IMGs 165/377 (43.8%). https://www.nrmp.org/wp-content/uploads/2024/08/Charting_Outcomes_IMG_2024-1.pdf ↩ ↩2

  9. National comp benchmarks and historical drift (Medscape 2019 $308k / 2023 $339k; 16th of 30); Medscape 2025 $388,000; BLS OEWS May 2024 mean $263,617. Barton Associates, Pathologist Salary Guide, 2026 (cites BLS May 2024, Doximity 2025, Medscape 2025). https://www.bartonassociates.com/pathologist-salary-guide/ ↩ ↩2 ↩3

  10. Doximity 2025 Physician Compensation Report (2024 data) — pathology median total comp ~$373,384; overall physician pay +3.7% in 2024. https://www.doximity.com/reports/physician-compensation-report/2025 ; BusinessWire summary (2025) https://www.businesswire.com/news/home/20250731656425/en/New-Doximity-Study-Shows-Modest-Physician-Pay-Growth-Amid-Deeper-Workforce-Strain-Reimbursement-Pressures ↩ ↩2 ↩3

  11. SalaryDr, Pathology Career Guide (2026) — median ~$390,000; P25–P75 ~$320,000–$450,000; early-career ~$315k, mid ~$395k, senior ~$480k (small verified-submission sample; directional — verify). https://www.salarydr.com/careers/pathology SalaryDr panel size: n=53. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  12. BLS OEWS, May 2024 — pathologist mean annual base wage $263,617 (excludes partnership/bonus). Via Barton Associates (source 9); BLS OEWS 29-1220-series. ↩ ↩2

  13. ResidencyAdvisor, "Physician Salary by Specialty: Pathology" (Dec 2025) — partnership $350k–$550k+; academic/subspecialty starts $230k–$380k; commercial/industry molecular $350k–$500k+; per-subspecialty ranges (dermpath, hemepath, molecular, cytopath, blood bank, forensic). https://residencyadvisor.com/resources/residency-application-guide/physician-salary-pathology-residency-guide Corrected 2026-08-17: ResidencyAdvisor is an aggregator rather than a benchmark survey, and it carries most of this page's setting and subspecialty bands because no survey publishes pathology at that grain. It is now named in the body at the partnership lever and at the head of the subspecialty list, so a reader knows what the bands rest on before reading them. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13

  14. Wage-inversion / reimbursement-pressure discussion (entry salaries up, locum/per-diem flat ~15 yr; AP fee cuts). Student Doctor Network forum thread (anecdotal, not survey data — verify). https://forums.studentdoctor.net/threads/crazy-pathology-wage-inversion-this-is-unsustainable.1401725/ ↩ ↩2 ↩3

  15. Academic vs non-academic hospital vs private-lab comp pattern. CAP, "The State of Pathologists' Job Market and Compensation" (2017 survey). https://www.cap.org/member-resources/articles/the-state-of-pathologists-job-market-and-compensation ↩ ↩2 ↩3

  16. BLS OEWS state mean base wage (May 2024) — highest NE $323,510 / IN $312,000 / NH $311,210 / MI $303,370; lowest CA $216,910 / MD $220,030 / NY $224,790 / DC $237,290. Via Barton Associates, 2026 (source 9). ↩ ↩2 ↩3

  17. Removed 2026-08-13. This footnote carried a ZipRecruiter posted-salary state ranking, relayed via Physicians Thrive, and the page used it as the opposing half of a "two datasets disagree" comparison against BLS. State geography now rests on the BLS wage survey alone. Original relay: Physicians Thrive, Pathologist Salary (2024), https://physiciansthrive.com/physician-compensation/pathologist-salary/ ↩ ↩2 ↩3

  18. Dermatopathology comp (~$270k avg; private/partner $380k–$550k+). AUA Med, Dermatopathologist Salary (2026, ZipRecruiter). https://www.auamed.org/blog/dermatopathologist-salary/ ↩ ↩2

  19. Forensic pathology low pay despite ~2x national shortage (~500,000 ME/coroner-referred deaths/yr; medicolegal < hospital pathology); typical $200k–$300k. ForensicsColleges, Forensic Pathologist Salary & Shortage (2025), citing NAME. https://www.forensicscolleges.com/careers/forensic-pathologist ↩ ↩2 ↩3

  20. Locum/per-diem rates ($98–$145/hr; ~$800–$1,000/day, agency markup to ~$1,250–$1,300/day; full-time locum ~$269k/yr). Barton Associates, Pathologist Salary Guide, 2026 (source 9). ↩

  21. Lab consolidation (Quest/LabCorp, hospital integration), reimbursement pressure, digital pathology/AI (whole-slide imaging, FDA-cleared aids), and molecular/IVD demand. Synthesis of comp research (Doximity/BusinessWire 2025; ResidencyAdvisor 2025; CAP). https://www.businesswire.com/news/home/20250731656425/en/New-Doximity-Study-Shows-Modest-Physician-Pay-Growth-Amid-Deeper-Workforce-Strain-Reimbursement-Pressures ↩ ↩2 ↩3 ↩4

  22. Pathology burnout ~41% (Medscape 2024) — among the lowest of specialties (vs EM ~63% highest; all-specialty ~49%). Medscape 2024 via Becker's ASC. https://www.beckersasc.com/asc-news/the-20-physician-specialties-with-the-highest-lowest-burnout-rates/ ⟳ Corrected 2026-08-17. 1 has recorded since 2026-08-13 that the AMA's 2025 Organizational Biopsy is free, primary, and publishes a pathology row at 28.3% against a 41.9% all-physician average, and that AMA is the instrument to rank from where it has a row. The fix never reached the reader: the dashboard, the wellbeing section's lead sentence and the figure caption all ranked pathology from Medscape 2024's 41%. AMA now leads in all three and Medscape 2024 is stated beside it as the second instrument. The direction was never in question — pathology is low-burnout on both surveys — but AMA's figure is thirteen points lower, and the ~49% and 41.9% baselines must never share a sentence. The EM-at-63% comparison stays on the Medscape side, because AMA's emergency medicine row is 49.8%. ↩

  23. Pathology happiness — ~62% happy outside work (Medscape 2024 lifestyle); ~88% "work-life balance possible" (Medscape 2025, 2nd highest). via HCN/Healthgrades. https://resources.healthgrades.com/pro/happiest-physicians-by-specialty ⟳ ↩

  24. Women 44% of active anatomic and clinical pathologists on 2022 data: AAMC, "Women are changing the face of medicine in America," https://www.aamc.org/news/women-are-changing-face-medicine-america, which prints the full 2004-vs-2022 comparison by specialty. The all-physician figure is 38.7% on 2024 data: AAMC, 2025 Key Findings, https://www.aamc.org/data-reports/data/2025-key-findings. Correction 2026-08-13: this page previously carried ~37.8% for practicing pathologists, from the 2018 AAMC report built on the 2017 AMA Masterfile, and described it as sitting close to the all-specialty average. It does not. Pathology runs about six points above the all-physician figure, and the two had been conflated in the Quick dashboard and in Who's in the field. ⟳ ↩

  25. Pathology (AP/CP) residents 54.7% women in academic year 2024-25: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf. Correction 2026-08-13: this page previously said "roughly half," which was right and a little low. ⟳ ↩

  26. Pathology resident race/ethnicity. ACGME, Data Resource Book, Academic Year 2024-2025, Table C.23 (Number of Active Residents by Specialty and Subspecialty and Race/Ethnicity), row "Pathology-anatomic and clinical": White 1,015, Asian 659, Hispanic/Latino or of Spanish origin 252, Black or African American 161, American Indian or Alaska Native 0, Native Hawaiian or Pacific Islander 0, multiple race/ethnicity 117, other 107, unknown 89, summing to 2,400. The same table's OVERALL row is 17,229 Hispanic, 11,291 Black, 160 American Indian or Alaska Native and 78 Native Hawaiian or Pacific Islander of 167,083 residents. https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf (2025). Corrected 2026-08-17: this footnote and the body bullet above it both said no pathology-specific URiM share is published and that representation is "generally reported as low." The share is published, in the same Data Resource Book this page already cites at 5 and 25, and at 17.2% it matches the all-resident average rather than falling below it. The AAMC Diversity in Medicine and Physician Specialty Data Report reference that stood here carried no URL and no figure. ⟳ ↩

  27. Job-market debate (oversupply narrative vs aging-workforce/shortage; workforce "undercounted by nearly 40%"; geography-dependent). CAP Newsroom, "New Study Reveals Pathologists Workforce Undercounted by Nearly 40%" (https://newsroom.cap.org/latest-news/new-study-reveals-pathologists-workforce-undercounted-by-nearly-40-/s/fa95b8fc-267e-44ef-83be-0816f630f2f0); "The current troubled state of the global pathology workforce," PMC (2024) (https://pmc.ncbi.nlm.nih.gov/articles/PMC11662708/); r/pathology, r/medicalschool, SDN (paraphrased). ↩ ↩2

  28. CAP, "Top 5 Reasons To Be A Pathologist." https://www.cap.org/member-resources/articles/top-5-reasons-to-be-a-pathologist ↩ ↩2

  29. AMA, "What it's really like in pathology—from 4 physicians who know." https://www.ama-assn.org/medical-students/preparing-residency/what-its-really-pathology-4-physicians-who-know ↩

  30. Doximity Op-Med, "Navigating the Pathology Interview Trail." https://opmed.doximity.com/articles/navigating-the-pathology-interview-trail ↩

Researched with AI assistance and reviewed by hand. How this site is made